If you have an implanted Medtronic DBS system, your replacement battery should also come from Medtronic.
Medtronic DBS Therapy is a precise system that works together to deliver therapy to control your symptoms. The system includes lead(s), extension(s), the device (neurostimulator) itself, and the battery.
You’ll have the best experience with DBS Therapy when all components of your system are from Medtronic. Components from other manufacturers — including batteries — are not interchangeable with Medtronic technology.
Maintaining a complete Medtronic system is the only way to get:
Approximately seven out of ten DBS-eligible patients with movement disorders may need an MRI within ten years of receiving their device.1 That’s why we developed the first full-body MR Conditional DBS system* — which gives you access to this important diagnostic imaging tool.
Other DBS systems are limited to head-only MRI, or worse, no MRI at all. Our full-body MR Conditional DBS systems make it safe to have scans anywhere on the body with some of our devices under certain conditions. (Including the requirement that your system must contain only Medtronic components. Systems comprised of components from multiple manufacturers are not MRI safe.)
Unlike other manufacturers, some of our devices can remain on during MRI, when programmed to certain settings, so your DBS therapy will not be interrupted. This may also improve MRI image quality, if it reduces movement symptoms related to your movement disorder.
Medtronic DBS systems are MR Conditional, which means they are safe for MRI scans only under certain conditions. If the conditions are not met, the MRI could cause tissue heating, especially at the implanted lead(s) in the brain, which may result in serious and permanent injury or death. Before having an MRI, always talk with the doctor who manages your DBS Therapy to determine your eligibility and discuss potential benefits and risks of MRI. For further information, please call Medtronic at 1-800-328-0810.
Falowski, S, Safriel Y, Ryan, M et al. The Rate of Magnetic Resonance Imaging in Patients with Deep Brain Stimulation. Stereotactic and Functional Neurosurgery. 2016; 94:147–153.